Respiratory failure & ventilation

Early reapplication of prone position during venovenous ECMO for acute respiratory distress syndrome: a prospective observational study and propensity-matched analysis

Ann Intensive CarePublished Prospective observational study

Authors' conclusion

Patients with severe ARDS placed in PP before VV-ECMO should continue PP after VV-ECMO support. This approach could increase the probability of successful weaning from VV-ECMO.

Study context

Population
Patients with severe acute respiratory distress syndrome (ARDS) treated with VV-ECMO who received prone positioning (PP) before ECMO45 matched per group
Participants
165 patients
Exposure
Early prone position during VV-ECMO vs supine
  • Pronen = 50
  • Supinen = 115reference
Outcome
Proportion of patients successfully weaned from VV-ECMO
Methodological detailspropensity-score matched
  • Propensity-score matched

Main finding

As reported in the abstract

Observational data: associations, not effects.

Further findings

Successful weaning from VV-ECMO (propensity-matched sample)

P = 0.035

60-day mortality (propensity-matched sample)

P = 0.035

  • Successful weaning from VV-ECMO (propensity-matched sample): propensity score-matched, 45 per group
  • 60-day mortality (propensity-matched sample): propensity score-matched, 45 per group

Physiological effects during PP

Significant increase in pressure of arterial oxygen (PaO2) without change in ventilator or ECMO settings
Tidal impedance shifted significantly to the dorsal region
Lung ultrasound scores significantly decreased in anterior and posterior regions

Original publication

Early reapplication of prone position during venovenous ECMO for acute respiratory distress syndrome: a prospective observational study and propensity-matched analysis. Ann Intensive Care. Published 20 August 2024. doi:10.1186/s13613-024-01365-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.